Scilex

SCLXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$14.268 M

$1.68 -8.20%

Close of 6 Nov 2026

As of 6 Nov 2026, Scilex (SCLX) has a market capitalization of $14.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$30.3M

#2863 by revenue

Earnings

-$374.1M

Loss-making

Shares outstanding

8,493,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Scilex lists more than one class of stock. Company figures above cover all classes combined.

SCLXW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#143Acumen PharmaceuticalsABOS$15.4M
#144Atyr PharmaATYR$15.4M
#145ScilexSCLX$14.3M
#146Dyadic InternationalDYAI$13.6M
#147BioCardiaBCDA$13.4M

What if Scilex were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,324,723

Per share 1,979,002× higher

Bitcoin $1.53T

$179,894.98

Per share 107,080× higher

Apple $5.02T

$590,578.43

Per share 351,535× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Scilex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.